---
layout: post
title: "太极集团：盐酸异丙嗪片通过仿制药一致性评价"
date: 2022-01-13 15:42:11 +0800
categories: emnews
tags: 东财滚动新闻
---
> 太极集团公告，盐酸异丙嗪片（12.5mg）通过仿制药一致性评价。（财联社）

<p style="display:none;height:1px;overflow:hidden;"> </p><!-- EM_StockImg_Start --><p style="text-align:center;"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=1.600129&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 600129_0" data-code="K 600129|1|1" data-code2="K 600129|1|2|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></p><!-- EM_StockImg_End --><p><span id="stock_1.600129"><a href="http://quote.eastmoney.com/unify/r/1.600129" class="keytip" data-code="1,600129">太极集团</a></span><span id="quote_1.600129"></span><span id="Info.3332"><a href="http://data.eastmoney.com/notices/" class="infokey">公告</a></span>，盐酸异丙嗪片(12.5mg)通过仿制药一致性评价。<br /></p><p class="em_media">（文章来源：财联社）</p>

<http://finance.eastmoney.com/news/1354,202201132246828324.html>

[返回东财滚动新闻](//finews.withounder.com/emnews/)｜[返回首页](//finews.withounder.com/)